In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  pegylated liposomal doxorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00629, GOG-0281, U10CA027469, U10CA180868, NCT02101788

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MITO-16 -MANGO-OV2b, 2012-004362-17, ENGOT-ov 17, NCT01802749

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AGO-OVAR 2.21 / ENGOT ov-18, NCT01837251

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100654, DOXILOVC3001, NCT01840943

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100983, ET743OVC3006, 2012-004808-34, NCT01846611

6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 14 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: ChangzhouJP, NCT02070523

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: APR-407, NCT02098343

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-17814, NCT02186834

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UCDCC#230, X05385, NCT01736943

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RB 12.032 - MYLY, NCT01848652

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FAHG20120926A, FAHGuangzhou012, NCT01872416

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 1300000710, NCT01990352

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GO28609, 2012-005776-34, NCT01991210

14.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: PO-CL-MM-PI-003854, NCT02188368

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: ATI0918-101, NCT01715168

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100961, DOXILNAP1002, 2013-000376-15, NCT01815294

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UCSF CC# 112516, UCSF Protocol Number 112516, NCT01902225

18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRST174.01, 2009-012996-82, NCT02131506

19.

Phase: No phase specified
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: 12316, NCI-2013-01948, NCT01970722

20.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSPECTYON (GINECO-OV229), NCT02163720
New Search